Spinraza is a survival motor neuron-2 (SMN2)-directed antisense oligonucleotide for treating spinal muscular atrophy (SMA) in pediatric and adult patients.
The recommended dosage of Spinraza is 12 mg (5 mL) per administration. Initiate Spinraza treatment with 4 loading doses. The first three loading doses should be administered at 14-day intervals. The 4th loading dose should be administered 30 days after the 3rd dose. A maintenance dose should be administered once every 4 months after that. Spinraza is administered intrathecally by, or under the direction of, healthcare professionals experienced in lumbar punctures.
Coagulation abnormalities and thrombocytopenia, including severe acute thrombocytopenia, have been observed after the administration of some antisense oligonucleotides. Because of the risk of thrombocytopenia and coagulation abnormalities from Spinraza, patients may be at increased risk of bleeding complications. One should perform a platelet count and coagulation laboratory testing at baseline and before each administration of Spinraza and as clinically needed.
Renal toxicity, including potentially fatal glomerulonephritis, has been observed after the administration of some antisense oligonucleotides. One should conduct quantitative spot urine protein testing (preferably a first-morning urine specimen) at baseline and before each dose of Spinraza. Consider repeat testing and further evaluation for urinary protein concentration greater than 0.2 g/L.
What documents are required to import Spinraza to India?
Spinraza (Nusinersen) injections can be imported only by patients or government hospitals in the patients’ name.
The following documentation is needed to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients Identity proof (issued by Govt of India)
How does the order confirm?
The order will be confirmed only after the receipt of:
- A valid prescription by healthcare professionals.
- Import permit if applicable.
Is Spinraza available in India?
Spinraza (Nusinersen) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Spinraza injection in India.
- Medicine Price.
- Finding Genuine and reliable sources from Canada, Europe, the USA and Australia
- Ensuring 100% transparency.
Spinraza can be made available to patients, doctors and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order for Spinraza will be confirmed only after receiving a valid prescription from the doctor and import permit.
IPN (Indian Pharma Network) can facilitate the supply of Spinraza (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable)
Please get in touch with +91-9310090915 | Toll-Free No: 1800-889-1064 or write us at firstname.lastname@example.org for Spinraza price in India.
We guarantee quality and delivery anywhere in the world per the buyer’s requirements.
Indian Pharma Network can source the Spinraza from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Spinraza?
Spinraza is the generic trade name for the drug Nusinersen.
What are the ingredients of the medicine Spinraza?
The active ingredient in the medicine is Nusinersen with inactive ingredients calcium chloride dihydrate, magnesium chloride hexahydrate, potassium chloride, sodium chloride, sodium phosphate dibasic anhydrous, sodium phosphate monobasic dihydrate, and Water for Injection.
Does the FDA approve Spinraza?
Yes, Spinraza is approved by the FDA. Date of approval: December 23, 2016.
What is Spinraza?
Spinraza is a survival motor neuron-2 (SMN2)-directed antisense oligonucleotide approved by the FDA for treating spinal muscular atrophy (SMA) in pediatric and adult patients.
What is the dosage and form of Spinraza supplied?
Spinraza comes in the form of single-dose vials in 12 mg/5 mL (2.4 mg/mL).
What are the most common side effects of Spinraza?
The most common side effects of Spinraza are lower respiratory infection, upper respiratory infection, and constipation.
How much does Spinraza cost in India?
The Spinraza cost in India is sensibly reasonable. To authenticate this rare disease drug, you can call or WhatsApp +91-9310090915 or email email@example.com.
What drug class is Spinraza?
Spinraza belongs to the antisense oligonucleotide class of drugs.
How do Spinraza work?
Spinraza is an antisense oligonucleotide designed to treat SMA caused by mutations in chromosome 5q that lead to SMN protein deficiency. According to in vitro assays and studies in transgenic animal models of SMA, Spinraza was shown to increase exon 7 inclusion in SMN2 messenger ribonucleic acid (mRNA) transcripts and the production of full-length SMN protein.
Is it safe to buy Spinraza online?
To buy Spinraza (Nusinersen) online, always look for an authentic, legitimate, WHO-GDP and ISO-certified Pharmaceutical Wholesaler/Distributor/Supplier.
What are the Highlights of prescribing information for Spinraza?